Different Factors Affecting Human ANP Amyloid Aggregation and Their Implications in Congestive Heart Failure Atrial Amyloidosis and Congestive Heart Failure
2011

Factors Affecting Human ANP Amyloid Aggregation in Heart Failure

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): Lia Millucci, Eugenio Paccagnini, Lorenzo Ghezzi, Giulia Bernardini, Daniela Braconi, Marcella Laschi, Marco Consumi, Adriano Spreafico, Piero Tanganelli, Pietro Lupetti, Agnese Magnani, Annalisa Santucci

Primary Institution: Università degli Studi di Siena, Italy

Hypothesis

The study aims to establish a link between Congestive Heart Failure (CHF) and Isolated Atrial Amyloidosis (IAA) and to characterize the aggregation of Atrial Natriuretic Peptide (ANP).

Conclusion

The study found a significant prevalence of IAA in CHF patients and established that β-ANP is a key factor in ANP amyloid deposition.

Supporting Evidence

  • 85% of CHF patients showed immunohistochemical evidence of IAA.
  • ANP aggregation was significantly influenced by pH and temperature.
  • β-ANP was identified as a key seed for ANP fibril formation.

Takeaway

This study shows that a protein related to heart function can clump together in sick hearts, which might lead to more heart problems.

Methodology

The study used immunohistochemistry and various in vitro techniques to analyze ANP aggregation in heart tissue samples from CHF patients.

Limitations

The study relies on ex vivo analysis and may not fully capture in vivo conditions.

Participant Demographics

The study included 40 CHF patients, with a mean age of 59.4 years, comprising 22 males and 18 females.

Digital Object Identifier (DOI)

10.1371/journal.pone.0021870

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication